{"id":10211,"date":"2026-06-22T13:57:18","date_gmt":"2026-06-22T10:57:18","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=10211"},"modified":"2026-06-22T13:57:18","modified_gmt":"2026-06-22T10:57:18","slug":"esprit-turning-the","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/esprit-turning-the\/","title":{"rendered":"ESPRIT: Turning the <120 mmHg Target Into Real-World Practice."},"content":{"rendered":"<p>ESPRIT: Turning the &lt;120 mmHg Target Into Real-World Practice.<\/p>\n<p>\u2022\u2060 \u2060New JACC editorial highlights the ESPRIT trial, showing that intensive BP control (SBP &lt;120 mmHg) is feasible even in primary care settings.<br \/>\n\u2022\u2060 \u206062.5% of patients achieved intensive BP targets with only ~1.3 additional antihypertensive medications and 1.5 extra clinic visits compared with standard treatment.<br \/>\n\u2022\u2060 \u2060Benefits of intensive BP lowering were consistent regardless of hypertension duration or baseline BP control status.<br \/>\n\u2022\u2060 \u2060Findings support guideline trends favoring more intensive BP control, particularly in high cardiovascular-risk patients.<br \/>\n\u2022\u2060 \u2060Success was attributed to a standardized treatment protocols.<\/p>\n<p>Take-home message: Intensive BP control is not only effective\u2014it can be realistically implemented with modest increases in treatment intensity and follow-up.<\/p>\n<p>Source : Medical News CME, June 2026<br \/>\nCommentary based on the JACC editorial by Yu-Jie Zuo and Ji-Guang Wang (Shanghai, China). DOI: 10.1016\/j.jacc.2026.03.041.<\/p>\n<p><a href=\"https:\/\/www.jacc.org\/doi\/10.1016\/j.jacc.2026.03.041\">https:\/\/www.jacc.org\/doi\/10.1016\/j.jacc.2026.03.041<\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ESPRIT: Turning the &lt;120 mmHg Target Into Real-World Practice. \u2022\u2060 \u2060New JACC editorial highlights the ESPRIT trial, showing that intensive BP control (SBP &lt;120 mmHg) is feasible even in primary care settings. \u2022\u2060 \u206062.5% of patients achieved intensive BP targets with only ~1.3 additional antihypertensive medications and 1.5 extra clinic visits compared with standard treatment. [&hellip;]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-10211","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10211","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=10211"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10211\/revisions"}],"predecessor-version":[{"id":10212,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10211\/revisions\/10212"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=10211"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=10211"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=10211"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}